You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Wegovy

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Exposure to Wegovy During Pregnancy

Not yet recruiting
  • Pregnancy
  • +2 more
  • No Intervention
  • (no location specified)
May 22, 2023

Safety of Exposure to Wegovy During Pregnancy

Not yet recruiting
  • Pregnancy
  • +2 more
  • No Intervention
  • (no location specified)
Aug 16, 2022

Obesity Trial in Loma Linda (Semaglutide, Orlistat, Phentermine/Topiramate)

Recruiting
  • Obesity
  • Loma Linda, California
    Novo Nordisk Investigational Site
Jan 24, 2023

PCOS (Polycystic Ovary Syndrome), Semaglutide Trial in Peking (Metformin Hydrochloride 500 MG, Semaglutide, 1.34 mg/mL,

Not yet recruiting
  • PCOS (Polycystic Ovary Syndrome)
  • Semaglutide
  • Metformin Hydrochloride 500 MG
  • +4 more
  • Peking, Beijing, China
    PekingUFH
Jan 18, 2023

Obesity Trial in Philadelphia (Behavioral Treatment, Placebo, Semaglutide 2.4 MG/0.75 ML Subcutaneous Solution [WEGOVY])

Recruiting
  • Obesity
  • Behavioral Treatment
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Center for Weight and Eating Disorder
Sep 19, 2022

Obesity, Bariatric Surgery, Binge Eating Disorder Trial in France (Data collection, Blood sampling, Questionnaires)

Not yet recruiting
  • Obesity
  • +6 more
  • Data collection
  • +2 more
  • Bondy, France
  • +13 more
May 31, 2023

Non-alcoholic Fatty Liver Disease Trial in Zagazig (Rybelsus Oral Product, Ozempic Injectable Product, Tocopherol and/or Actos)

Recruiting
  • Non-alcoholic Fatty Liver Disease
  • Rybelsus Oral Product
  • +2 more
  • Zagazig, Sharkia, Egypt
    Zagazig University
Apr 1, 2023

Obesity, Interstitial Lung Disease, COPD Trial (Semaglutide Pen Injector)

Not yet recruiting
  • Obesity
  • +4 more
  • Semaglutide Pen Injector
  • (no location specified)
Feb 15, 2023

Alcohol Abuse, Alcohol Addiction, Alcohol Dependence Trial in Frederiksberg (Semaglutide Injectable Product, Placebo)

Recruiting
  • Alcohol Abuse
  • +3 more
  • Semaglutide Injectable Product
  • Placebo
  • Frederiksberg, Denmark
    Psychiatric Center Copenhagen, Frederiksberg Hospital
Jun 13, 2023

Obesity, Diabetes Type 2 Trial in Lancaster (Semaglutide Pen Injector [Ozempic])

Recruiting
  • Obesity
  • Diabetes Type 2
  • Semaglutide Pen Injector [Ozempic]
  • Lancaster, Pennsylvania
    Amish Research Clinic
Jul 29, 2022

Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial (Efinopegdutide, Semaglutide, Placebo)

Not yet recruiting
  • Non-alcoholic Fatty Liver Disease
  • +4 more
  • (no location specified)
May 17, 2023

Anti-obesity Pharmacotherapy and Inflammation

Not yet recruiting
  • Obesity
  • Liraglutide or Semaglutide
  • Phentermine-Topiramate combination
  • New Orleans, Louisiana
  • +1 more
Mar 3, 2023

Atherosclerosis, Cardiovascular Diseases, Diabetes, Type 2 Trial in North York, Scarborough (Semaglutide Pen Injector)

Recruiting
  • Atherosclerosis
  • +3 more
  • Semaglutide Pen Injector
  • North York, Ontario, Canada
  • +1 more
May 12, 2023

NAFLD Trial in Richmond (Semaglutide Pen Injector, Placebo)

Not yet recruiting
  • NAFLD
  • Semaglutide Pen Injector
  • Placebo
  • Richmond, Virginia
    Virginia Commonwealth University
Jul 22, 2022

Asthma Trial in Nashville (Semaglutide Pen Injector 2.4mg weekly, Placebo)

Not yet recruiting
  • Asthma
  • Semaglutide Pen Injector 2.4mg weekly
  • Placebo
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jun 22, 2022

Idiopathic Intracranial Hypertension, Intracranial Pressure, Obesity Trial in Glostrup, Odense (drug, dietary supplement,

Recruiting
  • Idiopathic Intracranial Hypertension
  • +5 more
  • Glostrup, Denmark
  • +1 more
Sep 7, 2023

Obesity Trial in Anaheim (PF-07081532, Semaglutide)

Recruiting
  • Obesity
  • Anaheim, California
    Anaheim Clinical Trials, LLC
Jan 27, 2023

Type 2 Diabetes, Impaired Glucose Tolerance, Non-Alcoholic Fatty Liver Disease Trial (Semaglutide Pen Injector, Placebo)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • +3 more
  • Semaglutide Pen Injector
  • Placebo
  • (no location specified)
Jul 27, 2022

Obesity, Obese, Overweight or Obesity Trial in New Zealand (biological, drug, other)

Recruiting
  • Obesity
  • +2 more
  • Bimagrumab
  • +2 more
  • Anniston, Alabama
  • +23 more
Feb 1, 2023

Fibrosis, Liver, Type 2 Diabetes in Obese, Non-Alcoholic Fatty Liver Disease Trial in La Jolla (Semaglutide, Placebo)

Recruiting
  • Fibrosis, Liver
  • +2 more
  • La Jolla, California
    University of California, San Diego
Aug 25, 2023

Alcohol Use Disorder Trial in Tulsa (Semaglutide, Placebo)

Not yet recruiting
  • Alcohol Use Disorder
  • Tulsa, Oklahoma
    OSU Biomedical Imaging Center
Jun 5, 2023

Gastric Content of Volunteers Fasting and Using

Completed
  • Pneumonia, Aspiration
  • Anesthesia
  • semaglutide use
  • Sao Paulo, Brazil
    Hospital Israelita Albert Einstein
Dec 1, 2023